#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Thomas Sciascia Email
Co-Founder, Chief Science Officer . Trevi Therapeutics
How to contact Thomas Sciascia
Join and see Thomas's contact info for free!t**************@trevitherapeutics.com
GROWJO
The Free Company & People Database
Current Roles
Trevi Therapeutics
Get all of our best features!
About
Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. Trevi is currently developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease. The conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Founded in 2011, Trevi is headquartered in New Haven, CT.Trevi Therapeutics Address
195 Church StreetNew Haven, CT
United States